Forward Industries trades at 29.7% discount to net asset value on common shares alone

Forward Industries’ Nasdaq-listed Solana treasury vehicle trades at a steep discount to net assets on common shares alone, but the gap narrows dramatically when accounting for warrants and options that could dilute existing holders. The valuation puzzle hinges on share count assumptions that carry real consequences for investors comparing FWDI stock to direct SOL ownership.

• Common shares trade at a 29.7% discount to net asset value; fully diluted shares shrink that gap to 2.4%.
• Forward holds 8.73 million SOL as of November 9, up 226,396 SOL in six weeks at an average cost of $75 per SOL.
• The difference between narrow and broad share counts hinges on 13.4 million sponsor warrants with a penny exercise price and activation hurdles at $27.75, $37 and $46.25.

• 29.7% Discount of FWDI to net asset value using common shares alone
• 8.73M SOL holdings as of November 9, representing 1.5% of Solana supply
• $5.53 Share price used in November 9 capitalization snapshot
• $600.2M Net asset value reported as of November 9, 2026

CryptoSlate reported that Forward Industries disclosed a mid-quarter update on November 10 showing its Nasdaq-traded shares (FWDI) trading at a 29.7% discount to net asset value when measured against common shares alone. Using a $5.53 share price and $600.2 million in net assets as of November 9, the discount evaporates to just 2.4% when fully diluted share counts are applied. The spread between these two measures reflects a fundamental uncertainty about future ownership structure that will shape returns for current investors.

Sponsor warrants create the valuation gap between common and fully diluted counts

The narrower calculation counts 76.3 million common shares outstanding, resulting in the 29.7% discount. The fully diluted figure rises to 105.9 million shares by adding warrants, options and restricted stock units, most of which remain unvested or out-of-the-money. The largest single addition is 13.4 million sponsor warrants granted to advisors and lead investors with a one-cent exercise price.

These warrants do not activate immediately. Forward’s prospectus filed November 9 describes the warrants as exercisable in three equal tranches after closing prices reach 150%, 200% and 250% of the $18.50 placement purchase price for 20 of 30 trading days following registration effectiveness. Those trigger levels translate to $27.75, $37 and $46.25 per share, subject to adjustment. If exercised for cash at the penny strike, the 13.4 million warrants would generate only about $134,000 for Forward’s treasury.

The warrants also permit cashless exercise, which would allow holders to convert them into shares without paying the one-cent strike price.

Middle count recognizes vested claims but excludes most sponsor warrants

A third measure sits between the common and fully diluted figures: an in-the-money count of 90.3 million shares. This includes 12.3 million vested warrants at a zero display price, 689,010 vested and unvested options, and 1.05 million unvested restricted stock units. Using this narrower approach, the discount to NAV widens to 17.3% when the exercise value of in-the-money options is added to NAV. Forward’s November 9 snapshot indicated those two option categories would contribute about $3.4 million in value if both vested and exercised for cash.

Forward’s June 30 quarterly filing describes management restricted stock units with service-only vesting in quarterly installments over four years, and performance stock units that vest only when specified company performance measures are achieved. The broadest count captures 875,324 unvested performance units, but does not establish the likelihood or timing of their vesting.

Six-week SOL accumulation and new financing reshape the growth equation

Beyond the capitalization puzzle, Forward disclosed concrete operational progress in its fiscal first quarter. The company added 226,396 SOL in just six weeks ending November 9, purchasing at an average cost of $75 per SOL. This brought holdings to 8.73 million SOL, or approximately 1.5% of Solana’s circulating supply, with SOL per fully diluted share rising to 0.0824 from 0.0806 at quarter-end September 30.

Chief Investment Officer Ryan Navi said in the company statement that the additions “mark a strong start to our fiscal year” and that Forward is “putting our all-weather SOL++ strategy into action.” The company secured a $50 million credit facility at SOFR plus 150 basis points from a federally chartered, FDIC-insured bank, with a two-year term and SOL collateral that remains staked and earning native rewards. Forward also committed up to $50 million to USHP, a tokenized index tracking U.S. home prices, in what it describes as a co-anchored $100 million launch.

The company added Barclays as a sales agent to its at-the-market equity offering program alongside existing partner Cantor, though only 529,257 shares sold for approximately $12.1 million gross through November 6.

The BlockWest read. Forward’s discount to NAV hinges entirely on assumption about which warrants will trigger and exercise, and when. The sponsor warrants require SOL to appreciate 50 percent above the placement price just to begin vesting in tranches. That creates a binomial scenario for shareholders: if SOL appreciates sharply, dilution cascades; if it stagnates, those warrants expire worthless and the narrow discount vanishes. The credit facility and USHP commitment shift Forward toward generating dollar income streams, a structural change that moves beyond pure SOL accumulation.

Investors face conflicting metrics: the 29.7% discount on common shares signals potential value, but trigger schedules on 13.4 million sponsor warrants remain untested. Forward’s disclosed equity sales through November 6 reached only $12.1 million of the available at-the-market capacity, meaning the pace and magnitude of future dilution depend on capital-raising decisions management has yet to make under the freshly expanded program with Barclays.

BlockWest is a news publication. Nothing here is investment advice. Read our disclaimer and editorial policy.